ACCESSION: MSBNK-SMB_Measured-HSA014P0321002
RECORD_TITLE: Annotated; 5-Thymidylic acid; LC-ESI-QFT; MS2; NEGATIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 13
COMMENT: RAW_SPEC {'EL02-neg_1812': {'bp': 119536.0, 'sum': 327091.0}, 'EL17-neg_1805': {'bp': 98565.0, 'sum': 287309.0}, 'EL06-neg_1804': {'bp': 97856.0, 'sum': 289909.0}, 'EL18-neg_1793': {'bp': 92079.0, 'sum': 250809.0}, 'EL15-neg_1817': {'bp': 89064.0, 'sum': 269371.0}, 'EL19-neg_1816': {'bp': 86785.0, 'sum': 279643.0}, 'EL03-neg_1807': {'bp': 84977.0, 'sum': 259266.0}, 'EL14-neg_1807': {'bp': 78904.0, 'sum': 231602.0}, 'EL20-neg_1822': {'bp': 73554.0, 'sum': 221520.0}, 'EL01-neg_1810': {'bp': 71881.0, 'sum': 225493.0}, 'EL08-neg_1804': {'bp': 68061.0, 'sum': 227481.0}, 'EL16-neg_1804': {'bp': 64976.0, 'sum': 232335.0}, 'EL13-neg_1815': {'bp': 63199.0, 'sum': 224026.0}}
COMMENT: RETENTION_TIME_STDEV 0.011
COMMENT: PRECURSOR_M/Z_RAW 321.049333
COMMENT: PRECURSOR_M/Z_STDEV 0.000116
COMMENT: PRECURSOR_IN_MS1 mz 321.049287; int 18.906; delta(ppm) 0.879424
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.115; C10H15N2O8P; [M-H]1; delta(ppm) -0.114887
COMMENT: PROPOSED_MF MS-FINDER 4.006; C10H15N2O8P; [M-H]-; delta(ppm) -0.115364
COMMENT: PROPOSED_MF MS-FINDER 2.372; C5H10N10O5S; [M-H]-; delta(ppm) 2.893424
COMMENT: PROPOSED_MF MS-FINDER 2.328; C11H19N2O3PS2; [M-H]-; delta(ppm) -2.822160
COMMENT: PROPOSED_MF MS-FINDER 2.270; C13H6N8O3; [M-H]-; delta(ppm) 0.863779
COMMENT: PROPOSED_MF MS-FINDER 2.232; C11H11N6O4P; [M-H]-; delta(ppm) -4.281104
COMMENT: PROPOSED_MF MS-FINDER 2.193; C7H7N12O2P; [M-H]-; delta(ppm) 4.083115
COMMENT: PROPOSED_MF MS-FINDER 2.173; C8H18O11S; [M-H]-; delta(ppm) -1.305045
COMMENT: PROPOSED_MF MS-FINDER 2.117; C13H14N4O2S2; [M-H]-; delta(ppm) 2.322738
COMMENT: PROPOSED_MF MS-FINDER 2.090; C12H20O4P2S; [M-H]-; delta(ppm) 2.533281
COMMENT: PROPOSED_MF MS-FINDER 2.054; C6H14N10S3; [M-H]-; delta(ppm) 0.186611
COMMENT: PROPOSED_MF MS-FINDER 2.053; C4H16N6O7P2; [M-H]-; delta(ppm) 3.103966
COMMENT: PROPOSED_MF MS-FINDER 2.034; C21H10N2S; [M-H]-; delta(ppm) 0.293096
COMMENT: PROPOSED_MF MS-FINDER 1.948; C5H18N6O4S3; [M-H]-; delta(ppm) 4.352389
COMMENT: PROPOSED_MF MS-FINDER 1.835; C9H22O6S3; [M-H]-; delta(ppm) -4.011835
COMMENT: PROPOSED_MF MS-FINDER 1.776; C13H22OS4; [M-H]-; delta(ppm) 3.781702
COMMENT: PROPOSED_MF SIRIUS5_Sirius 17.077; C10H15N2O8P; [M-H]-; delta(ppm) -0.115364
COMMENT: PROPOSED_MF SIRIUS5_Sirius 12.418; C8H20O9P2; [M-H]-; delta(ppm) -5.260237
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.166; C12H11ClN6O3; [M-H]-; delta(ppm) -69559.467936
COMMENT: PROPOSED_MF SIRIUS5_Sirius 3.213; C11H19N2O3PS2; [M-H]-; delta(ppm) -2.822160
COMMENT: PROPOSED_MF SIRIUS5_Sirius 0.952; C15H15ClN2O2S; [M-H]-; delta(ppm) -69549.114423
COMMENT: PROPOSED_MF SIRIUS5_Sirius 0.209; C17H10N2O5; [M-H]-; delta(ppm) -7.500387
COMMENT: PROPOSED_MF SIRIUS5_Sirius 0.159; C15H9F3N2O3; [M-H]-; delta(ppm) 0.116069
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.681; C16H19BrO2; [M-H]-; delta(ppm) -0.864098
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.812; C13H14N4O2S2; [M-H]-; delta(ppm) 2.322738
COMMENT: PROPOSED_MF SIRIUS5_Sirius -1.270; C12H18O6S2; [M-H]-; delta(ppm) 6.488534
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.990; C10H15N2O8P; [M-H]-; delta(ppm) -0.115364
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.010; C8H20O9P2; [M-H]-; delta(ppm) -5.260237
COMMENT: PROPOSED_MF SIRIUS6_Sirius 18.485; C10H15N2O8P; [M-H]-; delta(ppm) -0.115364
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.659; C11H15ClN2O7; [M-H]-; delta(ppm) -69555.861543
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.723; C7H16FN2O9P; [M-H]-; delta(ppm) -3.674473
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.046; C8H20O9P2; [M-H]-; delta(ppm) -5.260237
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.887; C12H11ClN6O3; [M-H]-; delta(ppm) -69559.467936
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.882; C6H11N8O6P; [M-H]-; delta(ppm) 8.248925
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.564; C8H14F3N2O6P; [M-H]-; delta(ppm) 7.501205
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.494; C6H16Cl2N6O5; [M-H]-; delta(ppm) -69553.555492
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.397; C8H16ClFN2O8; [M-H]-; delta(ppm) -69558.942759
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.933; C7H11ClN8O5; [M-H]-; delta(ppm) -69548.620360
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.871; C10H15N2O8P; [M-H]-; delta(ppm) -0.115364
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.052; C7H16FN2O9P; [M-H]-; delta(ppm) -3.674473
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.030; C8H20O9P2; [M-H]-; delta(ppm) -5.260237
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.026; C6H11N8O6P; [M-H]-; delta(ppm) 8.248925
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.016; C8H14F3N2O6P; [M-H]-; delta(ppm) 7.501205
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C11H15ClN2O7; [M-H]-; delta(ppm) -69555.861543
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 6.000; GYOZYWVXFNDGLU-XLPZGREQSA-N; C10H15N2O8P; DTMP
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 5.000; GYOZYWVXFNDGLU-UHFFFAOYSA-N; C10H15N2O8P; 5'-Thymidylic acid CollisionEnergy:205060
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.500; QYKRUCBLHROXCK-UHFFFAOYSA-N; [M-H]-; CC1=NC=C(COP(O)(O)=O)C(CNOCC(O)=O)=C1O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.250; GYOZYWVXFNDGLU-XLPZGREQSA-N; [M-H]-; CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.222; QSULJYOIONNJQJ-UHFFFAOYSA-N; [M-H]-; O=P(O)(O)CCOCCOCCOCCP(=O)(O)O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.507; DGBZHMALEIDADV-UHFFFAOYSA-N; [M-H]-; NCCCN1C2=CC(O)=C(O)C=C2SC2=C1C=C(Cl)C=C2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.500; UVSIFVBCHJEYJP-UHFFFAOYSA-N; [M-H]-; ClC1=CC=C(NS(=O)(=O)C2=CC=C3CCNCC3=C2)C=C1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.938; GYOZYWVXFNDGLU-XLPZGREQSA-N; [M-H]-; 5-Thymidylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.625; QYKRUCBLHROXCK-UHFFFAOYSA-N; [M-H]-; 4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; GYOZYWVXFNDGLU-XLPZGREQSA-N; [M-H]-; 5-Thymidylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.446; QYKRUCBLHROXCK-UHFFFAOYSA-N; [M-H]-; 4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; GYOZYWVXFNDGLU-XLPZGREQSA-N; [M-H]-; [(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl dihydrogen phosphate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.173; XXYIANZGUOSQHY-XLPZGREQSA-N; [M-H]-; [(2R,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] dihydrogen phosphate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -3.495; GYOZYWVXFNDGLU; [M-H]-; Deoxy TMP
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -61.427; XXYIANZGUOSQHY; [M-H]-; 3''-Thymidylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -67.314; NZONAJJJGMXZKE; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -106.925; GDFCYFBMOFTZLD; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -413.506; QYKRUCBLHROXCK; [M-H]-; 2-[[3-hydroxy-2-methyl-5-(phosphonooxymethyl)pyridin-4-yl]methylamino]oxyacetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.370; GYOZYWVXFNDGLU; [M-H]-; Deoxy TMP
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -9.033; GYOZYWVXFNDGLU; [M-H]-; Dtmp
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -67.950; GDFCYFBMOFTZLD; [M-H]-; O(4)-Methyldeoxythymidine monophosphate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -104.601; XXYIANZGUOSQHY; [M-H]-; Thymidine 3'-monophosphoric acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -116.768; NZONAJJJGMXZKE; [M-H]-; 3'-Deoxy-5-methyluridine 5'-(dihydrogen phosphate)
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -246.835; QYKRUCBLHROXCK; [M-H]-; 4'-Deoxy-4'-acetylyamino-pyridoxal-5'-phosphate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -276.725; QSULJYOIONNJQJ; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.338; GYOZYWVXFNDGLU; [M-H]-; Dtmp
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match 5-Thymidylic acid, GYOZYWVXFNDGLU-XLPZGREQSA-N; Matching to 6 measured spectra (Dot product > 0.7); Proposed by SIRIUS5_CSI with FDR < 0.05; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (2), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (1), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0001227;
CH$NAME: 5-Thymidylic acid
CH$NAME: [(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl dihydrogen phosphate
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C10H15N2O8P
CH$EXACT_MASS: 322.056602
CH$SMILES: CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)O)O
CH$IUPAC: InChI=1S/C10H15N2O8P/c1-5-3-12(10(15)11-9(5)14)8-2-6(13)7(20-8)4-19-21(16,17)18/h3,6-8,13H,2,4H2,1H3,(H,11,14,15)(H2,16,17,18)/t6-,7+,8+/m0/s1
CH$LINK: CHEBI CHEBI:17013
CH$LINK: HMDB HMDB0001227
CH$LINK: INCHIKEY GYOZYWVXFNDGLU-XLPZGREQSA-N
CH$LINK: PUBCHEM CID:9700
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 3.087
MS$FOCUSED_ION: ION_TYPE [M-H]-
MS$FOCUSED_ION: PRECURSOR_M/Z 321.049287
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-004i-9601000000-5101f9af5b0113bbdce7
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  78.9576265 999.0000 78.957615 0.3926 0.00 0.7909 13 ?
  96.9682084 165.7376 96.968217 0.8766 11.58 0.7182 13 ?
  125.0343681 257.3148 125.034425 0.8718 27.34 0.8273 13 ?
  128.0339545 112.3667 128.034018 0.9763 38.18 0.2485 11 ?
  176.9949682 78.2267 176.995171 1.6611 11.68 0.7455 12 f{C5H6O5P1}/-4.88ppm,p-C5H8N2O3
  195.0062665 253.3106 195.005692 0.8513 22.75 0.8000 13 f{C5H8O6P1}/-0.67ppm,p-C5H6N2O2
  199.8508554 178.0736 199.850323 0.9857 40.99 -0.0424 11 ?
  200.8515870 64.1003 200.851063 1.3144 19.83 0.0545 12 ?
  321.0489043 235.8620 321.049233 0.9905 22.80 1.0000 11 f{C10H14N2O8P1}/-1.31ppm,p
PK$NUM_PEAK: 9
PK$PEAK: m/z int. rel.int.
  78.957627 999.00 999
  96.968208 165.74 165
  125.034368 257.31 257
  128.033954 112.37 112
  176.994968 78.23 78
  195.006267 253.31 253
  199.850855 178.07 178
  200.851587 64.10 64
  321.048904 235.86 235
//
